Cargando…
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens
Bladder cancer biomarkers currently approved by the Food and Drug Administration are insufficiently reliable for use in non-invasive clinical diagnosis. Verification/validation of numerous biomarker candidates for BC detection is a crucial bottleneck for novel biomarker development. A multiplexed li...
Autores principales: | Tsai, Cheng-Han, Chen, Yi-Ting, Chang, Ying-Hsu, Hsueh, Chuen, Liu, Chung-Yi, Chang, Yu-Sun, Chen, Chien-Lun, Yu, Jau-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089400/ https://www.ncbi.nlm.nih.gov/pubmed/30112103 http://dx.doi.org/10.18632/oncotarget.24578 |
Ejemplares similares
-
Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers
por: Chen, Yi-Ting, et al.
Publicado: (2019) -
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
por: Chen, Yi-Ting, et al.
Publicado: (2018) -
Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022) -
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
por: Lin, Jia-You, et al.
Publicado: (2021) -
The efficacy of semi-quantitative urine protein-to-creatinine (P/C) ratio for the detection of significant proteinuria in urine specimens in health screening settings
por: Chang, Chih-Chun, et al.
Publicado: (2016)